Sign in

Private company

Elusys Therapeutics

Logo: elusys.com3

Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases.2 It is headquartered in Morristown.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1998Founded1
  • Industrypharmaceutical industry1
  • HeadquartersMorristown1
  • Websitewww.elusys.com
  • Legal formprivately held company1

See how the biggest companies compare on our leaderboards

Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases.2

Timeline

  1. 1998Founded Founded1

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$478.8M 2008–2025
Money received by yearMoney received by year, 2008–2025: $478.8M in all. Federal contracts $478.8M.$0$20M$40M$60M$80M2008 · Federal contracts: $883.6K20082009 · Federal contracts: $18.8M2010 · Federal contracts: $41.3M20102011 · Federal contracts: $26.4M2012 · Federal contracts: $64.6M20122013 · Federal contracts: $23.5M2014 · Federal contracts: $23.7M20142015 · Federal contracts: $44.9M2016 · Federal contracts: $4.7M20162017 · Federal contracts: $3.2M2018 · Federal contracts: $18.1M20182019 · Federal contracts: $4.0M20202021 · Federal contracts: $50.0M2022 · Federal contracts: $31.0M20222024 · Federal contracts: $68.4M20242025 · Federal contracts: $55.3M2025
Figures by year
YearFederal contractsTotal
2025$55.3M$55.3M
2024$68.4M$68.4M
2022$31.0M$31.0M
2021$50.0M$50.0M
2019$4.0M$4.0M
2018$18.1M$18.1M
2017$3.2M$3.2M
2016$4.7M$4.7M
2015$44.9M$44.9M
2014$23.7M$23.7M
2013$23.5M$23.5M
2012$64.6M$64.6M
2011$26.4M$26.4M
2010$41.3M$41.3M
2009$18.8M$18.8M
2008$883.6K$883.6K

Federal awards

Obligated amounts from USAspending.gov4, by calendar year, 2008–2025, for its registration. Obligations are what agencies committed, not always what was paid out. Contracts pay for goods and services; grants, loans and direct payments are assistance. Loans are charted at the face value of the loans listed here. An award’s amount below is its lifetime total, and some began before the years charted.

Largest contracts

  1. Dec 18, 2009$138.3M from Office of Assistant Secretary for Preparedness and Response: Biomedical (advanced)5 To ELUSYS THERAPEUTICS INC Award HHSO100201000026C
  2. May 1, 2024$124.5M from Office of Assistant Secretary for Preparedness and Response: Anthim (obiltoxaximab)6 To ELUSYS THERAPEUTICS INC Award 75A50324C00006
  3. Aug 6, 2021$79.9M from Office of Assistant Secretary for Preparedness and Response: Anthim letter contract7 To ELUSYS THERAPEUTICS INC Award 75A50121C00073
  4. Nov 2, 2015$45.0M from Office of Assistant Secretary for Preparedness and Response: Igf::ot::igf for other functions8 To ELUSYS THERAPEUTICS INC Award HHSO10033001T
  5. Apr 16, 2018$24.5M from Office of Assistant Secretary for Preparedness and Response: Igf::ot::igf for other functions9 To ELUSYS THERAPEUTICS INC Award 75A50118F33002

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9